Impact of National Health Policies and Antimicrobial Stewardship Programs on Antibiotic Utilization and Resistance Patterns in Healthcare Facilities

Abstract

The global escalation of antimicrobial resistance (AMR) is a profound public health threat linked to millions of deaths and devastating macroeconomic consequences. The primary biological driver of this crisis is selective pressure from inappropriate antibiotic utilization across human and agricultural sectors. To combat AMR, healthcare systems deploy multi-layered intervention models integrating macro-level national health policies with micro-level institutional Antimicrobial Stewardship Programs (ASPs). This review examines the quantitative impacts, structural designs, and administrative challenges of these initiatives. Evidence indicates that higher national policy governance scores are strongly associated with improved antibiotic use trends, though implementation remains severely underfunded in low- and middle-income countries. Locally, ASPs utilizing front-end restrictions and back-end prospective audits consistently reduce total antibiotic consumption by up to 28% and lower the use of high-risk broad-spectrum agents. Furthermore, diagnostic stewardship and selective laboratory reporting successfully steer clinicians toward rational prescribing. However, the ecological consequences on pathogen susceptibility are highly variable. While targeted restrictions have engineered substantial susceptibility rebounds in Klebsiella pneumoniae, Acinetobacter baumannii, and Staphylococcus aureus, they can also cause collateral selective shifts that increase resistance in alternative pathogen-drug pairs. Financially, ASPs achieve massive direct medication cost savings, yet top-down mandatory policy targets risk creating unintended behaviors. Clinicians facing rigid indicators may engage in regulatory circumvention, such as shifting broad-spectrum procurement out-of-pocket to retail pharmacies, which artificially deflates hospital metrics while burdening patients. Mitigating these systemic barriers requires balancing administrative mandates with supportive, face-to-face clinical modeling and comprehensive socio-ecological collective action.